Skip to main content
Journal cover image

Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity.

Publication ,  Journal Article
Pericak-Vance, MA; Speer, MC; Lennon, F; West, SG; Menold, MM; Stajich, JM; Wolpert, CM; Slotterbeck, BD; Saito, M; Tim, RW; Rozear, MP ...
Published in: Neurogenetics
September 1997

The Charcot-Marie-Tooth (CMT) neuropathies are a group of disorders exhibiting neurophysical, pathological and genetic heterogeneity. CMT2 is a diagnostic subtype of this group of disorders characterized by variable expression and age-of-onset and normal or slightly diminished nerve conduction velocities. Previously, linkage and heterogeneity had been reported in CMT2 with linked families localizing to chromosome 1p (CMT2A). Recently a second CMT2 locus has been described on chromosome 7 in a single large CMT2 family (CMT2D). We have performed pedigree linkage analysis on 15 CMT2 families (N = 371 individuals, 106 affected family members) and have confirmed linkage to chromosome 7. Furthermore, using both admixture and multipoint linkage analysis we show conclusive evidence for additional heterogeneity within this clinical subtype with evidence of families that exclude linkage to both the CMT2D and CMT2A regions. In addition, unlike the previous report we found no obvious consistent clinical differences between the linked family types.

Duke Scholars

Published In

Neurogenetics

DOI

ISSN

1364-6745

Publication Date

September 1997

Volume

1

Issue

2

Start / End Page

89 / 93

Location

United States

Related Subject Headings

  • Pedigree
  • Neurology & Neurosurgery
  • Microsatellite Repeats
  • Male
  • Lod Score
  • Humans
  • Genotype
  • Genetic Predisposition to Disease
  • Genetic Linkage
  • Genetic Heterogeneity
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pericak-Vance, M. A., Speer, M. C., Lennon, F., West, S. G., Menold, M. M., Stajich, J. M., … Vance, J. M. (1997). Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity. Neurogenetics, 1(2), 89–93. https://doi.org/10.1007/s100480050013
Pericak-Vance, M. A., M. C. Speer, F. Lennon, S. G. West, M. M. Menold, J. M. Stajich, C. M. Wolpert, et al. “Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity.Neurogenetics 1, no. 2 (September 1997): 89–93. https://doi.org/10.1007/s100480050013.
Pericak-Vance MA, Speer MC, Lennon F, West SG, Menold MM, Stajich JM, et al. Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity. Neurogenetics. 1997 Sep;1(2):89–93.
Pericak-Vance, M. A., et al. “Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity.Neurogenetics, vol. 1, no. 2, Sept. 1997, pp. 89–93. Pubmed, doi:10.1007/s100480050013.
Pericak-Vance MA, Speer MC, Lennon F, West SG, Menold MM, Stajich JM, Wolpert CM, Slotterbeck BD, Saito M, Tim RW, Rozear MP, Middleton LT, Tsuji S, Vance JM. Confirmation of a second locus for CMT2 and evidence for additional genetic heterogeneity. Neurogenetics. 1997 Sep;1(2):89–93.
Journal cover image

Published In

Neurogenetics

DOI

ISSN

1364-6745

Publication Date

September 1997

Volume

1

Issue

2

Start / End Page

89 / 93

Location

United States

Related Subject Headings

  • Pedigree
  • Neurology & Neurosurgery
  • Microsatellite Repeats
  • Male
  • Lod Score
  • Humans
  • Genotype
  • Genetic Predisposition to Disease
  • Genetic Linkage
  • Genetic Heterogeneity